SciLifeLab has welcomed their Majesties from the Netherlands and Sweden to learn more about technologies to study cells and initiatives for precision medicine.

“It is a major recognition for SciLifeLab to be selected as a site for this state visit and it was our pleasure to guide these distinguished visitors through a glimpse of the vast research resources and infrastructure that SciLifeLab offers,” says Ylva Engström, Professor at Stockholm University, and Chair of the SciLifeLab board.

Long-standing relations dating back to the 1600s

The visit on October 12th is part of the state visit from The Netherlands for which life science is one of the key topics. The purpose of the visit is to reaffirm and advance the excellent and long-standing relations between Sweden and the Netherlands dating back to the 1600s, states SciLifeLab in a press release.

The countries are working together to make Europe greener, more resilient, and economically stronger. In addition to life sciences, the focus of the State Visit is green innovation, maritime relations, and gender equality.

Strengthened cooperation between Dutch and Swedish researchers and companies will benefit both countries to work on innovative solutions, states SciLifeLab.

“During the site visit we focused on precision medicine and on technologies to visualize and study individual cells as well as their molecular properties.”

“We bring scientists together across traditional boundaries and foster collaborations with industry, health care, public research organizations, and international partners. During the site visit we focused on precision medicine and on technologies to visualize and study individual cells as well as their molecular properties,” says Mia Phillipson, Professor at Uppsala University, and Co-Director SciLifeLab.

MoUs signed

During the state visit the following Memorandum of Understandings (MoUs) regarding life sciences were also signed: an MoU between Uppsala Clinical Research Center and the European Cardiovascular Research Institute, an MoU between Scandinavian CRO AB and Cardialysis B.V., an MoU between Leiden University Medical Center, Lund University, and Skåne (Scania) University Hospital, and  a letter of intent (LoI) between CTC Clinical Trial Consultants AB and QPS.

Featured image: The King and Queen of the Netherlands, His Majesty King Willem-Alexander and Her Majesty Queen, and The King and Queen of Sweden, His Majesty King Carl XVI Gustaf and Her Majesty Queen Silvia visiting the national research infrastructure SciLifeLab. Charlotte Stadler, SciLifeLab/KTH is Head of the National Spatial Proteomics Facility and presented the facility together with Tony Ullman. Photo: SciLifeLab